TCIM
BIOL

TIAA CREF Investment Management’s Biolase, Inc. BIOL Stock Holding History

TIAA CREF Investment Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10
Closed -$309K – 3185
2014
Q1 		$309K Hold
10
– – ﹤0.01% 3043
2013
Q4 		$362K Hold
10
– – ﹤0.01% 3025
2013
Q3 		$243K Hold
10
– – ﹤0.01% 3040
2013
Q2 		$434K Buy
+10
New +$559K ﹤0.01% 2968

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

TIAA CREF Investment Management's BIOL Position: Q2 2014 in Review

TIAA CREF Investment Management sold out of Biolase, Inc. (BIOL) in Q2 2014, closing a stake of 10 shares — an estimated $309K sold.

TIAA CREF Investment Management first reported a position in BIOL in Q2 2013 and held it in 4 quarters. The position peaked at $434K in Q2 2013. 34 funds tracked by Wall St. Rank hold BIOL as of Q2 2014.

  • TIAA CREF Investment Management reported no remaining Biolase, Inc. position as of Q2 2014 after selling out during the quarter.
  • TIAA CREF Investment Management sold 10 Biolase, Inc. shares in Q2 2014, an estimated $309K.
  • TIAA CREF Investment Management first reported a position in Biolase, Inc. in Q2 2013 and held it in 4 quarters.
  • TIAA CREF Investment Management's Biolase, Inc. position peaked at $434K in Q2 2013.
  • 34 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2014.

Based on TIAA CREF Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.